Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3204-3212

  Kelly, K J ^a   Dominguez, Jesus H ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

acute kidney failure; anti inflammatory agents; diabetic nephropathies; inflammation; ischaemia

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; ERYTHROCYTE AGGREGATION; FIBROSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LONG TERM CARE; MALE; MICROVASCULAR ISCHEMIA; NONHUMAN; OBESITY; POSTISCHEMIC INFLAMMATORY SYNDROME; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; ZUCKER DIABETIC FATTY RAT;

ANIMALS; APOPTOSIS; BLOOD FLOW VELOCITY; CAPILLARY PERMEABILITY; DIABETIC NEPHROPATHIES; ERYTHROCYTE AGGREGATION; FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIA; KIDNEY; MALE; MYCOPHENOLIC ACID; NEPHRITIS; RATS; SCAVENGER RECEPTORS, CLASS E; SYNDROME;

EID: 77957223078     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq217     Document Type: Article

References (38)

1. Dunstan DW, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834
2. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, USA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
3. Hsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74: 101-107
4. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370
5. Hsu CY. Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 2007; 16: 221-226
6. Newsome BB, Warnock DG, McClellan WM et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008; 168: 609-616
7. Navarro JF, Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant 2005; 20: 2601-2604
8. Hirata K, Shikata K, Matsuda M et al. Increased expression of selec-tins in kidneys of patients with diabetic nephropathy. Diabetologia 1998; 41: 185-192
9. Muller GA, Markovic-Lipkovski J, Muller CA. Intercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis. Clin Nephrol 1991; 36: 203-208
10. Kelly KJ, Williams WW, Colvin RB et al. Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994; 91: 812-816
11. Kelly KJ, Williams WW Jr., Colvin RB et al. Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063
12. Kelly KJ, Wu P, Patterson CE, Temm C, Dominguez JH. LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes. Am J Physiol Renal Physiol 2008; 294: F1136-F1145
13. Tang SC, Leung JC, Chan LY, Tsang AW, Lai KN. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. J Am Soc Nephrol 2006; 17: 1633-1643
14. Dominguez JH, Mehta JL, Li D et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am J Physiol Renal Physiol 2008; 294: F110-F119
15. Kelly KJ, Burford JL, Dominguez JH. The post-ischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 2009; 297: F923-F931
16. Verzola D, Gandolfo MT, Ferrario F et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007; 72: 1262-1272
17. Dominguez J, Wu P, Packer CS, Temm C, Kelly KJ. Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy. Am J Physiol Renal Physiol 2007; 293: F670-F679
18. Kelly K, Sutton TA, Weathered N et al. Minocycline inhibits apopto-sis and inflammation in a rat model of ischemic renal injury. Am J Physiol 2004; 287: F760-F766
19. Campagnola PJ, Millard AC, Terasaki M, Hoppe PE, Malone CJ, Mohler WA. Three-dimensional high-resolution second-harmonic generation imaging of endogenous structural proteins in biological tissues. Biophysical J 2002; 81: 493-508
20. Dunn KW, Sandoval RM, Kelly KJ et al. Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol 2002; 283: C905-C916
21. Beyenbach KW. Kidneys sans glomeruli. Am J Physiol Renal Physiol 2004; 286: F811-F827
22. Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51: 1580-1587
23. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637
24. Kelly DJ, Stein-Oakley A, Zhang Y et al. Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2) 27 rats: attenuation with renin-angiotensin blockade. Nephrology (Carlton) 2004; 9: 7-13
25. Kumar D, Robertson S, Burns KD. Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem 2004; 259: 67-70
26. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2005; 2: e45
27. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MM. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. Faseb J 2003; 17: 908-910
28. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genesin renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997; 45: 50-56
29. Tashiro K, Makita Y, Shike Tet al. Detection of cell death of cultured mouse mesangial cells induced by oxidized low-density lipoprotein. Nephron 1999; 82: 51-58
30. Ishani A, Xue JL, Himmelfarb J et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2008; 20: 223-228
31. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17
32. Eugui EM, Almquist SJ, Muller CD, Allison AC. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991; 33: 161-173
33. Zatz R, Noronha IL, Fujihara CK. Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies. Am J Physiol Renal Physiol 2002; 283: F1167-F1175
34. Safirstein R, Megysesi J, Saggi SJ et al. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991; 261: F1095-F1101
35. Watanabe K, Konishi K, Fujioka M, Kinoshita S, Nakagawa H. The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem 1989; 264: 19559-19563
36. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of protein-uria in diabetic nephropathy. Nephron Physiol 2007; 106: p26-p31
37. Antus B, Mucsi I, Rosivall L. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives. Acta Physiol Hung 2000; 87: 5-24
38. Antus B, Exton MS, Rosivall L. Angiotensin II: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 2001; 14: 25-30